Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
Trendle
M C
MC
Tefferi
A
A
D015762:2-Chloroadenosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003839:Deoxyadenosines / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D003839:Deoxyadenosines; D015762:2-Chloroadenosine; C036854:2'-chloro-2'-deoxyadenosine